Log in

NASDAQ:MYOMyomo Stock Price, Forecast & News

+0.02 (+0.51 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $3.92
50-Day Range
MA: $3.78
52-Week Range
Now: $3.92
Volume112,133 shs
Average Volume484,663 shs
Market Capitalization$11.03 million
P/E RatioN/A
Dividend YieldN/A
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Current SymbolNASDAQ:MYO



Sales & Book Value

Annual SalesN/A



Market Cap$11.03 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable
+0.02 (+0.51 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Myomo (NASDAQ:MYO) Frequently Asked Questions

How has Myomo's stock been impacted by COVID-19 (Coronavirus)?

Myomo's stock was trading at $4.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MYO stock has decreased by 16.2% and is now trading at $3.92.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Myomo?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Myomo

When is Myomo's next earnings date?

Myomo is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for Myomo

How were Myomo's earnings last quarter?

Myomo, Inc. (NASDAQ:MYO) released its quarterly earnings data on Thursday, May, 14th. The company reported ($2.51) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.94) by $0.57. The business earned $1.01 million during the quarter, compared to analysts' expectations of $0.78 million.
View Myomo's earnings history

Has Myomo been receiving favorable news coverage?

News articles about MYO stock have trended very positive on Saturday, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Myomo earned a daily sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Myomo

Who are some of Myomo's key competitors?

What other stocks do shareholders of Myomo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Myomo investors own include Cocrystal Pharma (COCP), Amgen (AMGN), AbbVie (ABBV), American Airlines Group (AAL), Becton Dickinson and (BDX), Chevron (CVX), E I Du Pont De Nemours And Co (DD), Walt Disney (DIS), Dow Chemical (DOW) and Ford Motor (F).

Who are Myomo's key executives?

Myomo's management team includes the following people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 63)
  • Ms. Davie Mendelsohn RN, VP of Sales & Clinical Services (Age 64)
  • Mr. Jonathan Naft, VP & GM (Age 53)
  • Mr. Ralph A. Goldwasser, Chief Financial Officer (Age 70)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 68)

What is Myomo's stock symbol?

Myomo trades on the NASDAQ under the ticker symbol "MYO."

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $3.92.

How big of a company is Myomo?

Myomo has a market capitalization of $11.03 million.

What is Myomo's official website?

The official website for Myomo is www.myomo.com.

How can I contact Myomo?

The company can be reached via phone at 617-996-9058.

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.